Bernhard D - Search Results

1

Suberoylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P-glycoprotein-expressing cells.

Ruefli AA, Bernhard D, Tainton KM, Kofler R, Smyth MJ, Johnstone RW. Ruefli AA, et al. Among authors: bernhard d. Int J Cancer. 2002 May 10;99(2):292-8. doi: 10.1002/ijc.10327. Int J Cancer. 2002. PMID: 11979447

2

The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species.

Ruefli AA, Ausserlechner MJ, Bernhard D, Sutton VR, Tainton KM, Kofler R, Smyth MJ, Johnstone RW. Ruefli AA, et al. Among authors: bernhard d. Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10833-8. doi: 10.1073/pnas.191208598. Epub 2001 Sep 4. Proc Natl Acad Sci U S A. 2001. PMID: 11535817 Free PMC article.

3

Histone deacetylase inhibitors potently repress CXCR4 chemokine receptor expression and function in acute lymphoblastic leukaemia.

Crazzolara R, Jöhrer K, Johnstone RW, Greil R, Kofler R, Meister B, Bernhard D. Crazzolara R, et al. Among authors: bernhard d. Br J Haematol. 2002 Dec;119(4):965-9. doi: 10.1046/j.1365-2141.2002.03955.x. Br J Haematol. 2002. PMID: 12472574 Free article.

4

Enhanced MTT-reducing activity under growth inhibition by resveratrol in CEM-C7H2 lymphocytic leukemia cells.

Bernhard D, Schwaiger W, Crazzolara R, Tinhofer I, Kofler R, Csordas A. Bernhard D, et al. Cancer Lett. 2003 Jun 10;195(2):193-9. doi: 10.1016/s0304-3835(03)00157-5. Cancer Lett. 2003. PMID: 12767528

5

Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts.

Bernhard D, Skvortsov S, Tinhofer I, Hübl H, Greil R, Csordas A, Kofler R. Bernhard D, et al. Cell Death Differ. 2001 Oct;8(10):1014-21. doi: 10.1038/sj.cdd.4400914. Cell Death Differ. 2001. PMID: 11598799

6

Interaction between dexamethasone and butyrate in apoptosis induction: non-additive in thymocytes and synergistic in a T cell-derived leukemia cell line.

Bernhard D, Löffler M, Hartmann BL, Yoshida M, Kofler R, Csordas A. Bernhard D, et al. Cell Death Differ. 1999 Jul;6(7):609-17. doi: 10.1038/sj.cdd.4400531. Cell Death Differ. 1999. PMID: 10453071

7

p53-induced apoptosis in the human T-ALL cell line CCRF-CEM.

Geley S, Hartmann BL, Hattmannstorfer R, Löffler M, Ausserlechner MJ, Bernhard D, Sgonc R, Strasser-Wozak EM, Ebner M, Auer B, Kofler R. Geley S, et al. Among authors: bernhard d. Oncogene. 1997 Nov 13;15(20):2429-37. doi: 10.1038/sj.onc.1201399. Oncogene. 1997. PMID: 9395239

8

Gene expression profiles of proliferating vs. G1/G0 arrested human leukemia cells suggest a mechanism for glucocorticoid-induced apoptosis.

Tonko M, Ausserlechner MJ, Bernhard D, Helmberg A, Kofler R. Tonko M, et al. Among authors: bernhard d. FASEB J. 2001 Mar;15(3):693-9. doi: 10.1096/fj.00-0327com. FASEB J. 2001. PMID: 11259387

9

c-Myc does not prevent glucocorticoid-induced apoptosis of human leukemic lymphoblasts.

Löffler M, Ausserlechner MJ, Tonko M, Hartmann BL, Bernhard D, Geley S, Helmberg A, Kofler R. Löffler M, et al. Among authors: bernhard d. Oncogene. 1999 Aug 12;18(32):4626-31. doi: 10.1038/sj.onc.1202820. Oncogene. 1999. PMID: 10467407

10

Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts.

Bernhard D, Ausserlechner MJ, Tonko M, Löffler M, Hartmann BL, Csordas A, Kofler R. Bernhard D, et al. FASEB J. 1999 Nov;13(14):1991-2001. doi: 10.1096/fasebj.13.14.1991. FASEB J. 1999. PMID: 10544182

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters